The U.S. Food and Drug Administration approved the first oral drug that can be urgently used to treat the new crown virus infection on the 22nd for the treatment of adults with mild to moderate covid-19 and children aged 12 years and older, as well as people with a higher risk of severe illness.

Reporter: Tan Jingjing, Hu Yousong, Tan Yixiao
Edit: Wang Hongliu
Produced by the Audio and Video Department of Xinhua News Agency